These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


180 related items for PubMed ID: 11744689

  • 1. Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells.
    Park SH, Lee SR, Kim BC, Cho EA, Patel SP, Kang HB, Sausville EA, Nakanishi O, Trepel JB, Lee BI, Kim SJ.
    J Biol Chem; 2002 Feb 15; 277(7):5168-74. PubMed ID: 11744689
    [Abstract] [Full Text] [Related]

  • 2. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW.
    J Biol Chem; 2005 Mar 18; 280(11):10047-54. PubMed ID: 15647279
    [Abstract] [Full Text] [Related]

  • 3. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 4. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S, Brattain MG.
    J Biol Chem; 2004 Jul 30; 279(31):32620-5. PubMed ID: 15155736
    [Abstract] [Full Text] [Related]

  • 5. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK, Cho YJ, Datta A, Anumanthan G, Ham AJ, Carbone DP, Datta PK.
    Neoplasia; 2011 Oct 30; 13(10):912-22. PubMed ID: 22028617
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y.
    Jin S, Scotto KW.
    Mol Cell Biol; 1998 Jul 30; 18(7):4377-84. PubMed ID: 9632821
    [Abstract] [Full Text] [Related]

  • 7. Ultraviolet irradiation represses TGF-β type II receptor transcription through a 38-bp sequence in the proximal promoter in human skin fibroblasts.
    He T, Quan T, Fisher GJ.
    Exp Dermatol; 2014 Oct 30; 23 Suppl 1(0 1):2-6. PubMed ID: 25234828
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional and post-transcriptional regulation of transforming growth factor beta type II receptor expression in osteoblasts.
    Chang W, Parra M, Ji C, Liu Y, Eickelberg O, McCarthy TL, Centrella M.
    Gene; 2002 Oct 16; 299(1-2):65-77. PubMed ID: 12459253
    [Abstract] [Full Text] [Related]

  • 9. MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.
    Lee BI, Park SH, Kim JW, Sausville EA, Kim HT, Nakanishi O, Trepel JB, Kim SJ.
    Cancer Res; 2001 Feb 01; 61(3):931-4. PubMed ID: 11221885
    [Abstract] [Full Text] [Related]

  • 10. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor.
    Uramoto H, Wetterskog D, Hackzell A, Matsumoto Y, Funa K.
    J Cell Sci; 2004 Oct 15; 117(Pt 22):5323-31. PubMed ID: 15454570
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
    Park SH, Birchenall-Roberts MC, Yi Y, Lee BI, Lee DK, Bertolette DC, Fu T, Ruscetti F, Kim SJ.
    Cell Growth Differ; 2001 Jan 15; 12(1):9-18. PubMed ID: 11205746
    [Abstract] [Full Text] [Related]

  • 12. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA.
    Nair AR, Boersma LJ, Schiltz L, Chaudhry MA, Muschel RJ.
    Cancer Lett; 2001 May 10; 166(1):55-64. PubMed ID: 11295287
    [Abstract] [Full Text] [Related]

  • 13. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
    Kim SN, Kim NH, Lee W, Seo DW, Kim YK.
    Mol Cancer Res; 2009 May 10; 7(5):735-44. PubMed ID: 19435809
    [Abstract] [Full Text] [Related]

  • 14. RhoB, not RhoA, represses the transcription of the transforming growth factor beta type II receptor by a mechanism involving activator protein 1.
    Adnane J, Seijo E, Chen Z, Bizouarn F, Leal M, Sebti SM, Muñoz-Antonia T.
    J Biol Chem; 2002 Mar 08; 277(10):8500-7. PubMed ID: 11741970
    [Abstract] [Full Text] [Related]

  • 15. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
    Liu Y, Zhong X, Li W, Brattain MG, Banerji SS.
    J Biol Chem; 2000 Apr 21; 275(16):12231-6. PubMed ID: 10766860
    [Abstract] [Full Text] [Related]

  • 16. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling.
    Quan T, He T, Kang S, Voorhees JJ, Fisher GJ.
    Am J Pathol; 2004 Sep 21; 165(3):741-51. PubMed ID: 15331399
    [Abstract] [Full Text] [Related]

  • 17. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y, Dufau ML.
    J Biol Chem; 2002 Sep 06; 277(36):33431-8. PubMed ID: 12091390
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.